Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice

Abstract

Selective heart rate reduction with ivabradine limits cardiac dysfunction and prevents the renovascular and cerebrovascular endothelial dysfunction associated with dyslipidaemia.